research safety

IGF-1 LR3 in a Stack What Researchers Should Know

Researchers exploring IGF-1 LR3 and CJC-1295 combination risks must understand that stacking these potent peptides can amplify dangerous side effects—from glucose dysregulation to joint degeneration—requiring careful protocol design and monitoring.